Why Are U.S. Analysts Downgrading Fresenius Medical Care?
By John Curran
Fresenius Medical Care is facing numerous claims from GranuFlo kidney dialysis heart attack class action lawsuit lawyers. Normally, stock analysts would not find that a concern. Wall Street is usually a rational being, using numbers rather than ethics in judging companies. Sometimes the two intersect, and it may be part of why analysts are downgrading the kidney failure treatment provider these days.
A cacophony of financial analyst “sell” ratings have come out in just the past week. Fresenius Medical Care is set to drop in stock value according to Nomura and should be sold according to JPMorgan Chase. HSBC may have incorporated NaturaLyte cardiac arrest side effects in its neutral rating, as would Goldman Sachs. A number of smaller investment bankers still hold out hope.
At first look, this would not seem to help GranuFlo kidney dialysis heart attack victims. It is a strong sign, though, that the company’s willingness to put hundreds of thousands of kidney failure patients at risk is hurting them financially. The company is looking to borrow $3 billion, likely in part for potential Fresenius Medical Care lawsuit settlements. Another issue may be reduced patient numbers as the elderly turn away from FMC kidney dialysis centers because of NaturaLyte cardiac arrest side effects.
Keep in mind, bankers worry about the numbers. GranuFlo kidney dialysis heart attack class action lawsuit lawyers worry about the well-being of their clients. As with any intersection of the business world and the consumer space that favors the public, it is a strong sign that there will be help for those who have suffered.
In addition to heart attack side effects, NaturaLyte hypoxemia side effects, or low oxygen in the blood, have also been reported. This can exacerbate the already shaky health of kidney failure patients, as does stroke.
If you or someone you know has been affected by NaturaLyte heart attack side effect risks, you can get help. Visit the Kidney Dialysis Heart Attack, GranuFlo & NaturaLyte Recall Class Action Lawsuit Settlement Investigation to get more information about potential legal remedies. Fill out the simple form there for a no-cost consultation about your options with a qualified NaturaLyte hypoxemia side effects lawsuit lawyer.
There are serious medical costs associated with heart attack side effects, kidney failure and potentially needing to switch kidney dialysis service providers. So get in touch with a qualified GranuFlo kidney dialysis heart attack lawsuit lawyer today. You may be eligible to pursue a legal remedy for medical bills and pain and suffering.
Updated October 16th, 2012
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
